Novo Nordisk
NVO
#21
Rank
โ‚น38.646 T
Marketcap
โ‚น8,892
Share price
2.57%
Change (1 day)
3.02%
Change (1 year)

Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.

Earnings for Novo Nordisk (NVO)

Earnings in 2024 (TTM): โ‚น1.403 Trillion

According to Novo Nordisk's latest financial reports the company's current earnings are โ‚น37.32 Billion. In 2023 the company made an earning of โ‚น1.303 Trillion, an increase over its 2022 earnings that were of โ‚น826.79 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Novo Nordisk from 1984 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) โ‚น1.403 T7.71%
2023 โ‚น1.303 T57.64%
2022 โ‚น826.79 B5.35%
2021 โ‚น784.80 B12.47%
2020 โ‚น697.78 B13.07%
2019 โ‚น617.13 B-3.35%
2018 โ‚น638.52 B1.79%
2017 โ‚น627.26 B4.52%
2016 โ‚น600.13 B9.42%
2015 โ‚น548.48 B8.24%
2014 โ‚น506.73 B3.45%
2013 โ‚น489.85 B19.02%
2012 โ‚น411.57 B15.21%
2011 โ‚น357.25 B17.71%
2010 โ‚น303.49 B24.78%
2009 โ‚น243.21 B10.62%
2008 โ‚น219.86 B55.97%
2007 โ‚น140.96 B7.07%
2006 โ‚น131.66 B18.18%
2005 โ‚น111.40 B11.33%
2004 โ‚น100.07 B
2002 โ‚น63.71 B-14.39%
2001 โ‚น74.41 B-52.82%
2000 โ‚น157.72 B250%
1999 โ‚น45.06 B31.21%
1998 โ‚น34.34 B34.31%
1997 โ‚น25.57 B11.46%
1996 โ‚น22.94 B9.03%
1995 โ‚น21.03 B-3.15%
1994 โ‚น21.72 B-0.67%
1993 โ‚น21.87 B45.38%
1992 โ‚น15.04 B-13.81%
1991 โ‚น17.45 B37.12%
1990 โ‚น12.72 B-0.79%
1989 โ‚น12.82 B26.2%
1988 โ‚น10.16 B24.97%
1987 โ‚น8.13 B-0.9%
1986 โ‚น8.20 B-7.78%
1985 โ‚น8.90 B24.87%
1984 โ‚น7.12 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-โ‚น102.38 Billion-107.19%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น857.41 B-39.77%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น581.16 Billion-140.82%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น625.74 B-56.04%๐Ÿ‡ซ๐Ÿ‡ท France